Respiratory disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: <First stage> 1. Subjects over 20 years old 2. Written informed consent <Second stage> 1. Subjects over 20 years old 2. Patients with respiratory diseases with cough 3. Written informed consent
Exclusion criteria
Exclusion criteria: <First stage> 1. Subjects judged inappropriate by the person in charge of this study <Second stage> 1. An unstable person who developed cardiovascular disease within 3 months 2. Persons who have serious illness such as advanced cancer and have a life expectancy of less than 6 months 3. Case of PS3/4 4. Persons with active infections that require treatment 5. Wounds at wearing site 6. Skin disorder (psoriasis) requiring treatment at the site of attachment 7. Subjects judged inappropriate by the person in charge of this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| <First stage> Determination of optimum application site Determination of definition of cough waveform <Second stage> Measurement of coughing frequency | — |
Countries
Japan
Contacts
Kobe University Graduate School of Medicine Division of Respiratory Medicine, Department of Internal Medicine